Antipsychotic use for neuropsychiatric symptoms in Alzheimer’s disease (AD) is common despite the increased risk of cardiovascular events and mortality. There is limited and inconsistent evidence on the possible risk of stroke. We assessed whether antipsychotic initiation increases the risk of stroke in pe...
The history of antipsychotics in nursing homes is one piece of a much larger, more complex puzzle. In many ways, it reflects the virtues and limitations of the entire health care system and those who provide care. None of the issues related to the use of antipsychotics are specific to these medications or ...
Antithrombotic therapy represents the mainstay of treatment and preventive measures in patients with atherothrombotic diseases. Both the incidence and prevalence of these diseases increase with age. Patients residing in the post-acute and long-term care (PALTC) setting are highly susceptible to atheroembol...